Primary Versus Secondary Closure of Stoma-Reversal Skin Wound
Sponsor
Ayub Teaching Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04785404
Collaborator
(none)
50
1
2
12
4.2
Study Details
Study Description
Brief Summary
to compare infection rate stoma reversal skin wound after primary or secondary closure
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
There will be two groups. In group A, skin will be stitched with prolene while in group B skin will be left open to follow up till 1 month and wound observed for infection according to CDC guidelines.
Study Design
Study Type:
Interventional
Actual Enrollment
:
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
patients will be randomly distributed to two groups. Group A patients will have skin wounds stithed after stoma reversal while in secondary closure group B, wound will be allowed to heal by secondary intentionpatients will be randomly distributed to two groups. Group A patients will have skin wounds stithed after stoma reversal while in secondary closure group B, wound will be allowed to heal by secondary intention
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Primary Versus Secondary Closure of Stoma-Reversal Skin Wound: Randomized Controlled Trial
Actual Study Start Date
:
Jan 1, 2020
Actual Primary Completion Date
:
Dec 31, 2020
Actual Study Completion Date
:
Dec 31, 2020
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: primary skin closure in this group, skin wound will be primarily closed |
Procedure: primary skin closure
skin will be stitched after stoma reversal to heal by primary intention
|
No Intervention: secondary skin closure skin will be left open to heal by secondary intention |
Outcome Measures
Primary Outcome Measures
- surgical site infection [30 days]
skin wound infection at surgical site will be observed on CDC guidelines
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- . All patients who undergo ileostomy or colostomy reversal will be included
Exclusion Criteria:
- included patients with reversal of stoma through laparatomy, post-operative anastomotic leak and co-morbidities like diabetes, Chronic liver disease, chronic kidney disease etc
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Ayub teaching hospital | Abbottābād | Khyber Pakhtunkhwa | Pakistan | 22040 |
Sponsors and Collaborators
- Ayub Teaching Hospital
Investigators
- Principal Investigator: Zanib Javed, FCPS, Ayub Teaching Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ayub Teaching Hospital
ClinicalTrials.gov Identifier:
NCT04785404
Other Study ID Numbers:
- AyubTH
First Posted:
Mar 5, 2021
Last Update Posted:
Jul 8, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ayub Teaching Hospital
Additional relevant MeSH terms: